cookie

Translate

sabato 30 luglio 2016

I contatti con il ministero della Salute continuano ....

Oggi ho letto la corrispondenza ricevuta dal Ministero della Salute in merito alla richiesta avanzata per la richiesta di autorizzazione sulla cannabis.

E' passato ormai quasi un anno e mezzo dalla richiesta. E' bello vedere come il Ministero si curi delle relazioni con attori esterni e mantenga vivo il dialogo. E' un peccato la chiusura del Ministro Lorenzin al dialogo.

Gli annunci contro la "cannabis legalizzata" ormai sono solo spot elettorali per cercare di conquistare consensi. Si vedano le elezioni Romane. Dove con triste caparbietà i due esponenti di una destra illiberale, hanno fatto una fine scontata.

Con questo post lancio una richiesta al Ministro Lorenzin per un incontro. Sicuro di non farLe cambiare idea, almeno vorrei provarLe come un confronto nel merito, come richiesto dall'intergruppo parlamentare, sia oggi più che mai una necessità della democrazia. 

E' ancora una maggiore necessità, la capacità che la politica possa affrontare, in maniera matura, il cambiamento che la società richiede.

Per questo, caro Ministro Lorenzin, sarei felice di poterLa  incontrare. La necessità di cambiamento, rende indispensabile la capacità di individuare interlocutori seri ed affidabili. Il cambiamento richiede coraggio ed è il momento di dimostrare il buon senso di averlo.

Cara Ministro, sarei felice di poter ricevere la Vostra autorizzazione e poter collaborare per il rilancio della coltivazione di cannabis, E' possibile cambiare l'Italia e numerose realtà del mondo antiproibizionista sarebbero felici di convincerVi a combattere insieme la diffusione di stupefacenti piuttosto che scontrarsi in un dibattito dove, il rischio di dimostrare una forte mancanza di competenze, è un rischio istituzionale che, i Ministeri, oggi non possono permettersi, per la serietà e professionalità delle figure che li compongono.

sabato 23 luglio 2016

Medical Marijuana Stocks Are Set to Skyrocket in 2016


Medical Marijuana Stocks Are Set to Skyrocket in 2016


Medical marijuana stocks are smashing the broader market by a huge margin in 2016. Companies like Cannabis Science Inc. (OTCMKTS: CBIS) and CannaGrow Holdings Inc. (OTCMKTS: CGRW) have seen shares soar 14.8% and 37% this year, respectively.
And we expect this to continue for five important reasons…

Bullish Reason for Medical Marijuana Stocks No. 5: Surging U.S. Sales

medical marijuana stocks
Sales of cannabis in the United States are projected to increase a hefty 25% this year to $6.7 billion. Driving this explosive growth will be the widespread acceptance of medical marijuana…
According to ArcView Market Research, marijuana use for medicinal purposes alone will bring in more than $10 billion in sales by 2020. That's up from less than $5 billion in 2015.
This massive rise in revenue will also increase the overall value of the market. Bank of America Merrill Lynch reported the U.S. marijuana industry could be worth roughly $30 billion annually by 2020. That's three times bigger than the National Football League's annual revenue of $10 billion.

Bullish Reason for Medical Marijuana Stocks No. 4: Growing List of Applications

Cannabis is used to treat a number of ailments and diseases. The list continues to expand as research continues to grow and bring new findings.
Editor's Note: This penny stock could double its current price – and also save a dying industry. Click here to learn more…
Medical marijuana has been known to treat the following diseases…
  • AIDS, Alzheimer's disease, arthritis, asthma, cancer, gastrointestinal disorders, epilepsy, glaucoma, migraines, multiple sclerosis, and various psychological conditions
Marijuana advocates hope new medical cannabis research will generate even more research and uses for cannabis. That will increase marijuana's credibility among medical professionals.

Bullish Reason for Medical Marijuana Stocks No. 3: Widespread Legalization

Marijuana legalization has become a huge movement across the United States, and it's not slowing down anytime soon.
Currently, there are 25 states – and Washington, D.C. – that allow medical marijuana use. The list of states includes…
  • Alaska, Arizona, California, Colorado, Connecticut, Delaware, Hawaii, Illinois, Maine, Maryland, Massachusetts, Michigan, Minnesota, Montana, Nevada, New Hampshire, New Jersey, New Mexico, New York, Ohio, Oregon, Pennsylvania, Rhode Island, Vermont, Washington
That list will increase this fall once more than 20 states vote on cannabis legalization in November.

Bullish Reason for Medical Marijuana Stocks No. 2: Growing Number of Dispensaries

As more states get on board with marijuana legalization, more dispensaries and other pot retailers will open up shop.
In fact, one state is making headlines this week as it prepares to open its first dispensary location…
Yesterday (Wednesday, July 20), the Florida Department of Health granted dispensary organization Trulieve permission to open a location in Tallahassee. It will be the state's first cannabis dispensary and will start delivering marijuana throughout the state. Trulieve is set to open in Tallahassee on Tuesday, July 26.
Editor's Note: You can bank profits on gold prices no matter where they move. All you need to do is check out our new guide on gold investing…
While Trulieve will only sell to a narrow range of patients, medical marijuana could soon be available for a wider range of conditions. Florida is one of the states set to hit the polls in November to vote on legalization.
More and more officials are starting to realize the benefits of medical marijuana to patients and states. In fact, 2016 could be a breakout year for medical marijuana.
This last reason shows why one of the most controversial topics of 2016 will be bullish for pot stocks in 2016…

Bullish Reason for Medical Marijuana Stocks No. 1: U.S. Politics

Both the Democratic and Republican stances on medical marijuana will fuel research and boost cannabis stocks in 2016.
On July 10 at the Democratic National Committee's 2016 National Platform, Democrats voted on an amendment to legalize marijuana in the United States. The pro-legalization camp won by a narrow margin, with the vote coming in at 81 to 80.
Democrats claimed they will support policies allowing more cannabis research to be done. They will also support changing laws to allow dispensaries to operate without being shuttered or prosecuted by the law.
Meanwhile, the Republican Party will be pressured to act on marijuana legislation at the federal level. It's leaning toward legalizing cannabis as fresh research expands on its effectiveness and revenue-generating possibilities.
Money Morning will continue to cover the cannabis market in 2016. Later this summer, we'll also share a carefully curated list of the best U.S. marijuana stocks to buy. So make sure you check back soon.

giovedì 21 luglio 2016

Il 25 luglio ... la ricorrenza del vero giorno del vaffanculo

Cari affezionati lettori, il 25 luglio non solo si discuterà della legalizzazione della cannabis, ma sarà anche una occasione di commemorazione di una delle più inutili operazioni proibizioniste italiane, di cui pochi, sfortunatamente, hanno memoria, ma che tutti dovrebbero ricordare.

Il 25 luglio infatti sarà la ricorrenza dell' Operazione Foglia, l'operazione con cui venne chiuso il portale marijuana.it.

Una operazione che coinvolse 60 perquisizioni in tutta italia, con risultati tragicomici. I risultati delle perquisizioni furono sequestri di pc di persone che tra loro neppure si conoscevano, libri sulla cucina della cannabis e poco altro. Oltre ad avere rovinato la vita di 60 persone e 60 famiglie.


BASTA DISCRIMINARE!

Ecco, il 25 luglio si dovranno ricordare tutte le persone ingiustamente incriminate per una abitudine che ha creato più danni perchè considerata illegale, che per avere relmente leso la vita delle persone.

E' proprio quanto ho portato, assieme all'associazione ASCIA, in parlamento nell'audizione tenutasi prima della bocciatura costituzionale della Fini giovanardi, una legge nata proprio dopo l'operazione foglia e che ha decretato il totale non senso, il totale fallimento di una vera caccia alle streghe, che come nel medioevo, ha portato sulla graticola persone innocenti, solo per il tornaconto di pochi.

Ricordate il 25 luglio, ricordate il giorno del vaffanculo, ricordate che questa guerra ha mietuto vittime tra innocenti e dato modo di perseguitare persone normali. Ricordate che i danni causati da questa legge sono stati di gran lunga più dannosi della cannabis stessa.

Il vero danno del proibizionismo è la capacità di condannare un comportamento sulla base di un pregiudizio. I danni della guerra alla droga devono finire e una nuova legge deve essere approvata. e se questo governo, questi parlamentari, non hanno capito che e' finito il tempo di creare inutili allarmismi sulla cannabis (si vedano i miseri risultati dei candidati sindaci di Roma, che hanno perso proprio per la loro anacronistica caccia al drogato), alle prossime elezioni assisteremo ad una ondata che li travolgerà tutti. 

Se non sarà questo governo o questo parlamento a legalizzarla, sarà sicuramente il prossimo, dove i sederi che occupano quelle poltrone, saranno democraticamente rimossi alle prossime elezioni.

venerdì 1 luglio 2016

Medical Marijuana, Inc. Receives 22 More Permits to Export Into Estimated $10-12 Billion Market in Mexico

Demand for CBD Hemp Oil in Mexico Increases as Mexico's Health Agency COFEPRIS Approves 22 Additional Import Permits for RSHO-X(TM)


SAN DIEGO, CA --(Marketwired - June 28, 2016) - Medical Marijuana, Inc. (OTC PINK: MJNA)announced today that Mexico's government has approved 22 additional import permits for Real Scientific Hemp Oil-X™ (RSHO-X™), expanding the Company's foothold into a market projected to eventually reach $10-12 billion annually.
On February 2, 2016, history was made when the government of Mexico issued two of the country's first permits to import Medical Marijuana, Inc.'s cannabidiol (CBD) product RSHO-X™ into the country to help two children suffering from severe forms of epilepsy. Since the first import permits were issued, the Mexico government has granted 22 additional permits to treat mostly adolescents in the country suffering from epilepsy.
"With its more than 120 million residents, Mexico represents a potentially vast market for Medical Marijuana, Inc.," the Company's CEO Dr. Stuart Titus said. "Our company's goal is 'access for all' and we have already made great strides in Mexico to get our products to the people there suffering with debilitating medical conditions. As the word continues to spread about the positive results families are experiencing from our products, we expect demand to continue to increase throughout the country."
HempMeds® Mexico, the distributor of Medical Marijuana, Inc.'s RSHO-X product in Mexico, has worked closely with RSHO-X advocate Raul Elizalde and his Por Grace Foundation, which was established to ensure families receive the right to health care and access to CBD hemp oil -- and to lobby for medical marijuana legalization in Mexico. The partners' combined efforts have led to major changes in Mexico's marijuana policy, as Mexico President Pena Nieto announced on April 21, 2016, his intent to move the country away from marijuana prohibition and towards prevention and regulation, including medicinal use.
President Nieto's marijuana reform bill, which authorizes the use and importation of all medicine made with marijuana, was approved by the Mexican Senate on June 15, 2016, but is now postponed for a new vote until September 2016 after Mexico legislators made changes to the original bill.
"The roadblocks medical marijuana legalization in Mexico is currently undergoing as President Nieto's reform bill works its way through the lawmaking process are expected with such major reform initiatives," said Dr. Titus. "Despite the pause on a definitive agreement from Mexico legislators, Medical Marijuana, Inc. and our partners in Mexico, including Raul Elizalde and his Por Grace Foundation, will continue to fight for Mexican families to expand and ensure legal access to medical marijuana for all those in need of it. In the meantime, RSHO-X continues to be available via a doctor's prescription as the first legal cannabis-based product within Mexico."
"We are optimistic that lawmakers in Mexico will be able to work together in putting together a complete marijuana reform bill that will benefit their citizens and continue their country's compassionate position on health," concluded Titus.

mercoledì 29 giugno 2016

Cannabis Entrepreneurs Worried as Big Businesses Move Into Industry

Steve DeAngelo, a veteran marijuana activist turned entrepreneur, warns that as marijuana prohibition ends and corporations start entering the industry, the pioneers could lose their place to disruptive technologies and business models.



Staff writer, Inc.

Marijuana legalization means that bigger corporate interests and institutional capital will enter the industry and start competing with the businesses and entrepreneurs who have been at it for decades.
But what does this mean for the industry's activists and pioneers who protested federal law, got arrested, and created the very industry that is attracting attention as one of the fastest-growing sectors in the U.S. economy? Entrepreneurs will be displaced, says Steve DeAngelo, founder of Harborside, the largest dispensary in the U.S., during his keynote address at the National Cannabis Industry Association business summit and expo in Oakland on Wednesday.
DeAngelo explains that there are only ten states in the U.S.that haven't reformed their cannabis laws in some way, there are eight ballot measures across different states to pass more reform this November, and the DEA could recognize that cannabis has medical benefits and might reschedule it this summer. All of this change will open the industry up to new entrants, bigger, more mainstream companies, and institutional investment. While legalization will be overwhelmingly positive, it won't be without negative effects on the current industry.
"This is going to the painful, it will hurt a lot of people who have been in the industry for decades," says DeAngelo. "It's going to hurt the very people who have helped bring the industry to today."
DeAngelo explained that industry newcomers have the ability to raise more money than legacy players because they have more connections to active capital markets outside of cannabis, he says. The new entrants will introduce disruptive business models that will force legacy businesses to change the way they have been doing things for decades.
"Legacy cannabis companies will need to learn how to adapt to a much more intense competitive environment and changing cultural landscape," says DeAngelo. "The folks coming in are not from the cannabis underground, they come with different values. There will be a process of adaptation for the legacy entrepreneurs."
A lot of the folks coming into the legal cannabis market are from other industries and have established political power and financial resources, says DeAngelo.
"Some of these players have been able to influence legislation to game the system to their benefit," says DeAngelo. "In Nevada, there is a provision that gives the distribution of cannabis exclusively to alcohol distribution companies. Guess who put that one in there?"
As the DEA and FDA look to possibly reschedule marijuana under the Controlled Substances Act, DeAngelo says if the federal government decides marijuana has medical benefits, it will help pharmaceutical companies enter the industry.
"It's evident that rescheduling will be a platform for Big Pharma to come in and take significant marketshare," says DeAngelo.
But as different formulations of cannabis hit the market, more people will try cannabis products.
"More sophisticated products like vape pens, transdermal patches, pills, topical creams, beverages and edibles will provide new adopters, newcomers to cannabis with more socially acceptable ways of using cannabis," says DeAngelo.
Once federal law is reformed and national brands are created, institutional investors will come into he space and start acquiring the strongest brands.
"The institutional investors are almost here, I can hear them in the hall way," says DeAngelo. "When they come, there will be a rich wave of exits, of acquisitions of companies who have played their cards right and been smart. I think those first acquisitions will be science companies, medical companies, companies that do genetics, others that explore new formulations. We will then see cannabis beverage companies that will be acquired by huge mainstream beverage corporations, companies that already make beverages at large scale."
As the cannabis industry changes, as more companies come into the market from outside of the industry, more customers will come to use cannabis.
"I don't think this is a bad thing," says DeAneglo. "All of this is a good thing. There is this monumental collision that is about to happen between the corporate world and cannabis. If we are ever going to achieve our goal, if this plant is ever going to get in the hands of people all over the world, this will be necessary."
Lastly, DeAngelo spoke directly to the legacy entrepreneurs and the newcomers.
The legacy entrepreneurs, DeAngelo says, are going to be called upon to make one more sacrifice--to let go of the cannabis plant and let it go completely mainstream, which will mean some pioneers will lose their place and new entrants will replace them.
"Let's make this sacrifice gracefully, we need to release this plant and allow her to go out, get wings, claim her destiny, to go out and help every single person she can help and we are not going to do it ourselves," says DeAngelo. "We have to welcome these newcomers, we need to let them help the industry."

venerdì 17 giugno 2016

Medical marijuana company gets the OK to build facility in Fall River

Marijuana will be grown and processed into medicine in a laboratory planned for the city’s biotech office park.


By Kevin P. O'Connor 

Herald News Staff Reporter  

Posted Jun. 10, 2016 at 3:47 PM

Updated Jun 10, 2016 at 3:56 PM 

FALL RIVER — Marijuana will be grown and processed into medicine in a laboratory planned for the city’s biotech office park.

Cannatech Medicinals Inc., a company based in Fall River, got Phase 3 approval from the state Department of Public Health to build a 30,000-square-foot facility at the Southcoast Life Science and Technology Park.
“We are hoping to break ground in the next 30 days,” said Dr. Henry Crowley, company president. “At this point, it is unlikely that anything will halt us.”
Cannatech got approval in December to buy 12 acres of land from the city’s Redevelopment Authority at a price of $1.02 million. That, plus a letter of support from Mayor Jasiel Correia II and a letter of non-opposition from Police Chief Daniel Racine, allowed the company to apply for a medical marijuana producer’s license.
That was received last week, so the company can begin plans for building, Crowley said.
“We are pulling permits now,” he added.
The facility in the office park will be dedicated to growing marijuana plants, testing the properties of different strains and producing oils, edibles and vaporizing agents for consuming the drug.
“Our goal to the consumers and to the community is to produce a high-quality medicine in a facility that will achieve the same standards as any high-tech pharmaceutical facility in the country,” Crowley said.
“Our ultimate goal is to provide a physician-directed method of treating diseases effectively with medical cannabis.”
The facility will be closed to the public. Cannatech purchased a lot on Hartwell Street to house a dispensary, Crowley said.
Cannabis remains illegal under federal law, but Massachusetts is one of several states that allow the production and distribution of the drug for medical purposes.
State voters will be asked in November of the recreational use of marijuana should be made legal. That vote won’t affect the work of Cannatech, Crowley said.
“We are a medical company and we are in it for medical purposes,” he said. “Our emphasis is on medical marijuana.
“We will have a strong and aggressive research and development department for that purpose.”
More than a decade of experiments in Israel and the Netherlands have shown different strains of cannabis effective at curbing epilepsy, shrinking cancerous tumors, slowing the development of glaucoma and dealing with chronic pain or side affects from HIV.
Crowley, who is an anesthesiologist and trained in pain management, said he has been following the development of cannabis medicines for more than five years. Derek Ross, who will be in charge of botany, is nationally recognized for his expertise in hybridizing strains of cannabis to target specific ailments, Crowley said.
“There is a lot of potential for this as a medicine for treating chronic disease,” he said.
Crowley and Steven Pimental, a partner in Cannatech, are both part of Same Day SurgiClinic, 272 Stanley St. It has been their intention from the start to locate in Fall River, Crowley said.


“The city of Fall River has been very helpful and very accommodating,” Crowley said. “The mayor and his legal team and Ken Fiola and his office have been fantastic.

“We want to be good neighbors. We will be giving back to the community.”
The plan is to have a facility built in six to eight months. There should be about 30 people employed there initially. The company should have products ready for sale in 16 to 18 months after the start of construction, Crowley said. The hope is to expand the plant in the next decade and grow to 100 employees, Crowley said.
There is a push, nationally, to remove cannabis from the list of federally prohibited drugs to allow medical research. Right now, cannabis, in all its forms, is a federal Schedule 1 drug, up there with heroin and cocaine.
“Until cannabis is de-scheduled, there probably won’t be a lot of research and development with it,” Crowley said. “When it is, we want to be at the forefront of it.”

Medical marijuana company gets the OK to build facility in Fall River

Archivio blog